HGF-H
|
Pancreatic Ductal Adenocarcinoma
|
HGF-H
|
Pancreatic Ductal Adenocarcinoma
|
FOLFIRINOX Resistant: C3 – Early Trials
|
FOLFIRINOX Resistant: C3 – Early Trials
|
HGF-H
|
RCC
|
HGF-H
|
RCC
|
pazopanib Resistant: C3 – Early Trials
|
pazopanib Resistant: C3 – Early Trials
|
HGF-H
|
RCC
|
HGF-H
|
RCC
|
sunitinib Resistant: C3 – Early Trials
|
sunitinib Resistant: C3 – Early Trials
|
HGF-H
|
RCC
|
HGF-H
|
RCC
|
sunitinib + pazopanib Resistant: C3 – Early Trials
|
sunitinib + pazopanib Resistant: C3 – Early Trials
|